Outcome measures in the clinical evaluation of ambulatory Charcot-Marie-Tooth 1A subjects
Laura Mori(Ospedale Policlinico San Martino), Angelo Schenone(University of Genoa), Giuseppe Piscosquito(University of Salerno), Alessio Signori(University of Genoa), Alessandro Picelli(University of Verona), Costanza Pazzaglia(Don Carlo Gnocchi Foundation), Nicola Smania(University of Verona), Gian Maria Fabrizi(University of Verona), Davide Pareyson(Fondazione IRCCS Istituto Neurologico Carlo Besta), Luca Padua(Università Cattolica del Sacro Cuore), Valeria Prada(Ospedale Policlinico San Martino)
European Journal of Physical and Rehabilitation Medicine
February 1, 2019
Cited by 25
Related Papers
Pathophysiology of Motor Dysfunction in Parkinson’s Disease as the Rationale for Drug Treatment and Rehabilitation
|Parkinson s Disease|2016|374
CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis
|Journal of Neurology Neurosurgery & Psychiatry|2014|342
Virtual Reality Telerehabilitation for Postural Instability in Parkinson’s Disease: A Multicenter, Single-Blind, Randomized, Controlled Trial
|BioMed Research International|2017|325
Scoring treatment response in patients with relapsing multiple sclerosis
|Multiple Sclerosis Journal|2012|258
Mutations in a Gene Encoding a Novel SH3/TPR Domain Protein Cause Autosomal Recessive Charcot-Marie-Tooth Type 4C Neuropathy
|The American Journal of Human Genetics|2003|213